- Home
- TWIN vs SAVA Comparison
TWIN vs SAVA Comparison
Compare TWIN & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- SAVA
- Stock Information
- Founded
- TWIN 1918
- SAVA 1998
- Country
- TWIN United States
- SAVA United States
- Employees
- TWIN N/A
- SAVA N/A
- Industry
- TWIN Industrial Machinery/Components
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- TWIN Industrials
- SAVA Health Care
- Exchange
- TWIN Nasdaq
- SAVA Nasdaq
- Market Cap
- TWIN 123.7M
- SAVA 70.5M
- IPO Year
- TWIN N/A
- SAVA N/A
- Fundamental
- Price
- TWIN $7.42
- SAVA $1.70
- Analyst Decision
- TWIN Strong Buy
- SAVA Buy
- Analyst Count
- TWIN 1
- SAVA 3
- Target Price
- TWIN $12.00
- SAVA $54.50
- AVG Volume (30 Days)
- TWIN 59.9K
- SAVA 807.5K
- Earning Date
- TWIN 05-07-2025
- SAVA 05-08-2025
- Dividend Yield
- TWIN 2.16%
- SAVA N/A
- EPS Growth
- TWIN N/A
- SAVA N/A
- EPS
- TWIN 0.29
- SAVA N/A
- Revenue
- TWIN $328,478,000.00
- SAVA N/A
- Revenue This Year
- TWIN N/A
- SAVA N/A
- Revenue Next Year
- TWIN N/A
- SAVA N/A
- P/E Ratio
- TWIN $25.48
- SAVA N/A
- Revenue Growth
- TWIN 11.49
- SAVA N/A
- 52 Week Low
- TWIN $6.16
- SAVA $1.15
- 52 Week High
- TWIN $15.86
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- TWIN 54.09
- SAVA 53.14
- Support Level
- TWIN $6.69
- SAVA $1.45
- Resistance Level
- TWIN $7.31
- SAVA $1.67
- Average True Range (ATR)
- TWIN 0.45
- SAVA 0.11
- MACD
- TWIN 0.12
- SAVA 0.05
- Stochastic Oscillator
- TWIN 91.97
- SAVA 91.67
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.